cAMP regulated EPAC1 supports microvascular density, angiogenic and metastatic properties in a model of triple negative breast cancer
Authors:
- 5 July 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 39 (10) , 1245-1253
Abstract
Breast cancer is a leading cause of cancer-related mortality in women. Triple-negative breast cancer (TNBC; HER2-, ER-/PR-) is an aggressive subtype prone to drug resistance and metastasis, which is characterized by high intratumor microvascular density (iMVD) resulting from angiogenesis. However, the mechanisms contributing to the aggressive phenotypes of TNBC remain elusive. We recently reported that down-regulation of exchange factor directly activated by cyclic AMP (cAMP), also known as EPAC1, leads to a reduction in metastatic properties including proliferation and cell migration in TNBC cell lines. Here, we report that EPAC1 supports TNBC-induced angiogenesis, tumor cell migration and invasiveness as well as pro-metastatic phenotypes in endothelial cells induced through the tumor secretome. Using an approach that integrates proteomics with bioinformatics and gene ontologies, we elucidate that EPAC1 supports a tumor-secreted network of angiogenic, cell adhesion and cell migratory pathways. Using confocal microscopy, we show that signaling molecules involved in focal adhesion, including Paxillin and MENA, are down-regulated in the absence of EPAC1, and electric cell substrate impedance sensing technique confirmed a role for EPAC1 on TNBC-induced endothelial cell permeability. Finally, to provide a translational bridge, we studied iMVD and therapy response using a primary human tumor explant assay, CANscriptTM, which suggests a link between therapy-modulated neovascularization and drug sensitivity. These data provide mechanistic insight into the role of EPAC1 in regulating the tumor microenvironment, iMVD and cancer cell-induced angiogenesis, a dynamic mechanism under drug pressure that may associate to treatment failure.Keywords
Funding Information
- Breast Cancer Alliance Young Investigator Award
This publication has 29 references indexed in Scilit:
- The Possible Role of Mena Protein and Its Splicing-Derived Variants in Embryogenesis, Carcinogenesis, and Tumor Invasion: A Systematic Review of the LiteratureBioMed Research International, 2013
- A Novel EPAC-Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and InvasionMolecular Pharmacology, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- A Computational Tool for Quantitative Analysis of Vascular NetworksPLOS ONE, 2011
- Triple-Negative Breast Cancer: An Unmet Medical NeedThe Oncologist, 2011
- Angiogenesis and Breast CancerJournal of Oncology, 2010
- Epac inhibits migration and proliferation of human prostate carcinoma cellsBritish Journal of Cancer, 2009
- PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated ExocytosisPhysiological Reviews, 2005
- Angiogenesis of Breast CancerJournal of Clinical Oncology, 2005
- Electric Cell–Substrate Impedance Sensing (ECIS) as a Noninvasive Means to Monitor the Kinetics of Cell Spreading to Artificial SurfacesExperimental Cell Research, 2000